Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

13
Number of overlapping holdings
56.5%
% of XDNA's 23 holdings also in GNOM
31.7%
% of GNOM's 41 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XDNA |
Weight in GNOM |
Overlap | |
---|---|---|---|---|
CRISPR THERAPEUTICS AG | 15.1% | 5.8% | 5.8% | |
INTELLIA THERAPEUTICS, INC. | 8.7% | 4.0% | 4.0% | |
BEAM THERAPEUTICS, INC. | 13.7% | 3.6% | 3.6% | |
AGILENT TECHNOLOGIES INC | 2.7% | 3.9% | 2.7% | |
EDITAS MEDICINE, INC. | 5.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
BEAM THERAPEUTICS, INC. | 10.1% | |
THERMO FISHER SCIENTIFIC INC | 9.5% | |
CRISPR THERAPEUTICS AG | 9.3% | |
PRIME MEDICINE, INC. | 5.9% | |
INTELLIA THERAPEUTICS, INC. | 4.7% | |
EDITAS MEDICINE, INC. | 4.2% | |
CARIBOU BIOSCIENCES, INC. | 3.9% | |
ABBVIE INC | 3.8% | |
POSEIDA THERAPEUTICS, INC. | 3.8% | |
VERVE THERAPEUTICS, INC. | 3.6% |
XDNA Underweight Relative to GNOM
ENI SPA-SPONSORED ADR | -7.5% | |
NATERA INC | -4.4% | |
ARROWHEAD PHARMACEUTICALS, INC. | -3.9% | |
10X GENOMICS INC CLASS A | -3.8% | |
ULTRAGENYX PHARMACEUTICAL IN | -3.8% | |
GENSCRIPT BIOTECH CORPORATION | -3.7% | |
PACIFIC BIOSCIENCES OF CALIF | -3.7% | |
BIOMARIN PHARMACEUTICAL INC | -3.5% | |
VERACYTE INC | -3.4% | |
BIO-TECHNE CORPORATION | -3.4% |